Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
Matthew C Woodruff1,2, Richard P Ramonell3, Doan C Nguyen3, Kevin S Cashman1, Ankur Singh Saini1, Natalie S Haddad3,4, Ariel M Ley3, Shuya Kyu3, J Christina Howell5, Tugba Ozturk5, Saeyun Lee1,3, Naveenchandra Suryadevara6, James Brett Case7, Regina Bugrovsky1, Weirong Chen1, Jacob Estrada1, Andrea Morrison-Porter3, Andrew Derrico3, Fabliha A Anam1, Monika Sharma1, Henry M Wu8, Sang N Le1,3, Scott A Jenks1,2, Christopher M Tipton1,2, Bashar Staitieh3, John L Daiss4, Eliver Ghosn1, Michael S Diamond7,9,10,11, Robert H Carnahan6,12, James E Crowe Jr6,12, William T Hu5, F Eun-Hyung Lee13, Ignacio Sanz14,15
- Department of Medicine, Division of Rheumatology, Lowance Center for Human Immunology, Emory University, Atlanta, GA, USA.
- Emory Autoimmunity Center of Excellence, Emory University, Atlanta, GA, USA.
- Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA, USA.
- MicroB-plex, Atlanta, GA, USA.
- Department of Neurology, Emory University, Atlanta, GA, USA.
- Vanderbilt Vaccine Center, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Medicine, Division of Infectious Diseases, Emory University, Atlanta, GA, USA.
- Department of Molecular Microbiology, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, USA.
- Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs, Washington University School of Medicine, St. Louis, MO, USA.
- Department of Pediatrics, Vanderbilt University Medical Center, Nashville, TN, USA.
- Department of Medicine, Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Emory University, Atlanta, GA, USA. f.e.lee@emory.edu.
- Department of Medicine, Division of Rheumatology, Lowance Center for Human Immunology, Emory University, Atlanta, GA, USA. ignacio.sanz@emory.edu.
- Emory Autoimmunity Center of Excellence, Emory University, Atlanta, GA, USA. ignacio.sanz@emory.edu.
Abstract
A wide spectrum of clinical manifestations has become a hallmark of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) COVID-19 pandemic, although the immunological underpinnings of diverse disease outcomes remain to be defined. We performed detailed characterization of B cell responses through high-dimensional flow cytometry to reveal substantial heterogeneity in both effector and immature populations. More notably, critically ill patients displayed hallmarks of extrafollicular B cell activation and shared B cell repertoire features previously described in autoimmune settings. Extrafollicular activation correlated strongly with large antibody-secreting cell expansion and early production of high concentrations of SARS-CoV-2-specific neutralizing antibodies. Yet, these patients had severe disease with elevated inflammatory biomarkers, multiorgan failure and death. Overall, these findings strongly suggest a pathogenic role for immune activation in subsets of patients with COVID-19. Our study provides further evidence that targeted immunomodulatory therapy may be beneficial in specific patient subpopulations and can be informed by careful immune profiling.
Presented By Matthew Woodruff | ORCID iD